Cytena

Freiburg Im Breisgau, Germany Founded: 2014 • Age: 12 yrs Acquired By CELLINK
Single cells are isolated using the cy-Clone device technology.

About Cytena

Cytena is a Healthcare company based in Freiburg Im Breisgau (Germany) founded in 2014, and was acquired by CELLINK in August 2019. Single cells are isolated using the cy-Clone device technology. Cytena has raised $4.59 million across 2 funding rounds from investors including CELLINK and High-Tech Gründerfonds. Its website cytena.com draws about 21 thousand monthly visits. Cytena offers products and services including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is CYTENA GmbH.

Company details

Founded in 2014, Cytena operates in the biotechnology sector focused on cell analysis tools. The cy-Clone device is utilized for separating individual cells, supporting biological drug development and genetic studies in cancer and stem cell research. An automated imaging system is integrated to encapsulate cells within droplets, enabling delivery to diverse substrates for further applications.

Key Metrics
  • Total Equity Funding
    $4.59M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.39M (USD), Series A

    Mar 2019

  • Investors
    CELLINK

    & 1 more

  • Acquired by
    CELLINK

    (Aug 2019)

Products & Services of Cytena

Cytena offers a comprehensive portfolio of products and services, including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS.

UP.SIGHT™ 2nd Gen
Single Cell Dispenser

Optimizes monoclonality proof and cell tracking in research.

F.SIGHT™ 2.0
Single Cell Dispenser

Enables rapid dispensing of fluorescent cells for assays.

C.SIGHT™ 2.0
Single Cell Dispenser

Facilitates powerful dispensing of unlabeled cells in workflows.

C.WASH™ PLUS
Microplate Washer

Automates washing and dispensing for reproducible lab processes.

Apps and channels of Cytena

its YouTube channel CYTENA has 152 subscribers and 30 videos.

CYTENA
YouTube 152 subscribers 30 videos Science & Technology
Open channel

Videos from Cytena

The most watched videos on Cytena's YouTube channel, CYTENA (152 subscribers). Click a video to play it here.

UP.SIGHT™ 2nd Gen | Single Cell Dispenser | Plate Imager | iPSC | Automated Cell Line Development
45.5K views
UP.SIGHT™ 2nd Gen | Single Cell Dispener | Plate Imager | Well Bottom Imaging | 3D Full Well Imaging
36.1K views
UP.SIGHT™ 2nd Gen | Welcome to a new era in cell line development | Cell Sorter | GMP Documentation
4.6K views
C.STATION™ | End-to-end stable cell line development workflow | Automated Cell Line Development
2.5K views

More on CYTENA.

Funding Insights of Cytena

Cytena has successfully raised a total of $4.59M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.39 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.59M
  • Total Rounds 2
  • Last Round Series A — $3.39M
  • First Round $1.2M

    (Apr 2015)

  • Investors Count 1

All 2 funding rounds of Cytena with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2019$3.39MSeries A–HTGF
–
Apr 2015$1.2MSeed–HTGF
–
Valuation history

2 investors in total: 2 institutional.

Investors in Cytena

Cytena has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CELLINK and High-Tech Gründerfonds.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are made in high-tech startups by HTGF.
htgf.deBonn, Germany
3D bioprinters and bioinks are developed for research applications.
2016cellink.comBoston, United States
Premium access

Investor details for Cytena

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Cytena

6 people are tracked at Cytena (2 in leadership, 4 in team).

NameRoleGroup
Fernando Aprile García
Director Of Applications Global R&dLeadership
Jolanda Scheenhart
Head Of Sales Europe - BiopharmaLeadership
Hesham Iftekhar Ahmad
Software EngineerTeam
Justin Loo
Sales Team Lead BiosciencesTeam
Jochen Huck
Software Project LeadTeam
Kushal Kumar Das
Sales Specialist Biopharma (central Europe)Team
Premium access

Complete people profiles for Cytena

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Cytena

4 dated milestones of Cytena across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cytena is founded.
  2. Funding First funding round of $1.2M.
  3. Funding Latest funding round, Series A, of $3.4M.
  4. Exit Acquired by CELLINK.

Web traffic of Cytena

The website of Cytena (cytena.com) receives about 20.8K visits a month.

  • Monthly visits
    20.8K

    ▼ 16.2% vs previous month

Similar websites

Websites whose visitors overlap most with Cytena. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
discover-echo.com
100%
28.3K#1,115,289View details
sptlabtech.com
90%
23.8K#1,239,423View details
ptglab.com
85%
#137,673View details
bio-techne.com
83%
218.1K#187,423View details
moleculardevices.com
80%
131.7K#329,224View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 26 similar websites and full traffic analytics for Cytena

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 26 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cytena

Premium access

Complete news archive for Cytena

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cytena

Cytena was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Cytena is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.

Cytena is a funded company, having raised a total of $4.59M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Apr 2015.

Founded in 2014, Cytena operates in the biotechnology sector focused on cell analysis tools. The cy-Clone device is utilized for separating individual cells, supporting biological drug development and genetic studies in cancer and stem cell research. An automated imaging system is integrated to encapsulate cells within droplets, enabling delivery to diverse substrates for further applications.

Cytena offers UP.SIGHTâ„¢ 2nd Gen, F.SIGHTâ„¢ 2.0, C.SIGHTâ„¢ 2.0, and C.WASHâ„¢ PLUS.

Cytena has 2 investors. Key investors include CELLINK, and High-Tech Gründerfonds.

Cytena operates through Cytena Gmbh.

Yes. Cytena was acquired by CELLINK in August 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available